相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Association of PD-1, PD-1 Ligands, and Other Features of the Tumor Immune Microenvironment with Response to Anti-PD-1 Therapy
Janis M. Taube et al.
CLINICAL CANCER RESEARCH (2014)
PD-1 identifies the patient-specific CD8+ tumor-reactive repertoire infiltrating human tumors
Alena Gros et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Ectopic lymphoid structures in primary cutaneous melanoma
Andrea Ladanyi et al.
PATHOLOGY & ONCOLOGY RESEARCH (2014)
Immune Monitoring of the Circulation and the Tumor Microenvironment in Patients with Regionally Advanced Melanoma Receiving Neoadjuvant Ipilimumab
Ahmad A. Tarhini et al.
PLOS ONE (2014)
Immune-Escape Markers in Relation to Clinical Outcome of Advanced Melanoma Patients Following Immunotherapy
Esther P. M. Tjin et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Understanding Dendritic Cells and Their Role in Cutaneous Carcinoma and Cancer Immunotherapy
Valerie R. Yanofsky et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2013)
Characteristics and Clinical Impacts of the Immune Environments in Colorectal and Renal Cell Carcinoma Lung Metastases: Influence of Tumor Origin
Romain Remark et al.
CLINICAL CANCER RESEARCH (2013)
Biomarkers for Immunostimulatory Monoclonal Antibodies in Combination Strategies for Melanoma and Other Tumor Types
Paolo A. Ascierto et al.
CLINICAL CANCER RESEARCH (2013)
BRAF Inhibition Is Associated with Enhanced Melanoma Antigen Expression and a More Favorable Tumor Microenvironment in Patients with Metastatic Melanoma
Dennie T. Frederick et al.
CLINICAL CANCER RESEARCH (2013)
Safety, Efficacy, and Biomarkers of Nivolumab With Vaccine in Ipilimumab-Refractory or -Naive Melanoma
Jeffrey S. Weber et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Tumor microenvironment converts plasmacytoid dendritic cells into immunosuppressive/tolerogenic cells: insight into the molecular mechanisms
Stephanie Demoulin et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2013)
Correlation among metallothionein expression, intratumoural macrophage infiltration and the risk of metastasis in human cutaneous malignant melanoma
E. Emri et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2013)
Phenotypic and Functional Characteristics of Blood Natural Killer Cells from Melanoma Patients at Different Clinical Stages
Giulia Fregni et al.
PLOS ONE (2013)
Mast cells, angiogenesis, and tumour growth
Domenico Ribatti et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2012)
Intratumoral neutrophils and plasmacytoid dendritic cells indicate poor prognosis and are associated with pSTAT3 expression in AJCC stage I/II melanoma
Trine O. Jensen et al.
CANCER (2012)
Immunological monitoring of the tumor immunoenvironment for clinical trials
Anatoli M. Malyguine et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
An immune-active tumor microenvironment favors clinical response to ipilimumab
Rui-Ru Ji et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
Neogenesis of Lymphoid Structures and Antibody Responses Occur in Human Melanoma Metastases
Arcadi Cipponi et al.
CANCER RESEARCH (2012)
Melanoma Cells Inhibit Natural Killer Cell Function by Modulating the Expression of Activating Receptors and Cytolytic Activity
Gabriella Pietra et al.
CANCER RESEARCH (2012)
Immunotype and Immunohistologic Characteristics of Tumor-Infiltrating Immune Cells Are Associated with Clinical Outcome in Metastatic Melanoma
Gulsun Erdag et al.
CANCER RESEARCH (2012)
Selective BRAF Inhibitors Induce Marked T-cell Infiltration into Human Metastatic Melanoma
James S. Wilmott et al.
CLINICAL CANCER RESEARCH (2012)
The Prognostic Value of FoxP3+ Tumor-Infiltrating Lymphocytes in Cancer: A Critical Review of the Literature
Ronald J. deLeeuw et al.
CLINICAL CANCER RESEARCH (2012)
On the dual roles and polarized phenotypes of neutrophils in tumor development and progression
H. Piccard et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2012)
Melanoma cells become resistant to NK-cell-mediated killing when exposed to NK-cell numbers compatible with NK-cell infiltration in the tumor
Mirna Balsamo et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2012)
Regression of melanoma metastases after immunotherapy is associated with activation of antigen presentation and interferon-mediated rejection genes
Rafael Carretero et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
PD-1 expression on Melan-A-reactive T cells increases during progression to metastatic disease
Holger Kroenig et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Tumor-Infiltrating Lymphocyte Grade Is an Independent Predictor of Sentinel Lymph Node Status and Survival in Patients With Cutaneous Melanoma
Farhad Azimi et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Objective assessment of blood and lymphatic vessel invasion and association with macrophage infiltration in cutaneous melanoma
Sarah J. Storr et al.
MODERN PATHOLOGY (2012)
Safety, Activity, and Immune Correlates of Anti-PD-1 Antibody in Cancer
Suzanne L. Topalian et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Prognostic Significance of Tumor-Associated Macrophages in Solid Tumor: A Meta-Analysis of the Literature
Qiong-wen Zhang et al.
PLOS ONE (2012)
Colocalization of Inflammatory Response with B7-H1 Expression in Human Melanocytic Lesions Supports an Adaptive Resistance Mechanism of Immune Escape
Janis M. Taube et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
12-Chemokine Gene Signature Identifies Lymph Node-like Structures in Melanoma: Potential for Patient Selection for Immunotherapy?
Jane L. Messina et al.
SCIENTIFIC REPORTS (2012)
NK cells sense tumors, course of disease and treatments Consequences for NK-based therapies
Giulia Fregni et al.
ONCOIMMUNOLOGY (2012)
PD-1 and BTLA and CD8+ T-cell exhaustion in cancer Exercising an alternative viewpoint
Cara Haymaker et al.
ONCOIMMUNOLOGY (2012)
Trial watch Prognostic and predictive value of the immune infiltrate in cancer
Laura Senovilla et al.
ONCOIMMUNOLOGY (2012)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis
M. J. M. Gooden et al.
BRITISH JOURNAL OF CANCER (2011)
The significant role of mast cells in cancer
Khashayarsha Khazaie et al.
CANCER AND METASTASIS REVIEWS (2011)
Tumor-infiltrating lymphocytes: apparently good for melanoma patients. But why?
Arcadi Cipponi et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
Prognostic impact of B-cell density in cutaneous melanoma
Andrea Ladanyi et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
Profound Coordinated Alterations of Intratumoral NK Cell Phenotype and Function in Lung Carcinoma
Sophia Platonova et al.
CANCER RESEARCH (2011)
CTLA4 Blockade Induces Frequent Tumor Infiltration by Activated Lymphocytes Regardless of Clinical Responses in Humans
Rong Rong Huang et al.
CLINICAL CANCER RESEARCH (2011)
Association between natural killer cells and regression in melanocytic lesions
Kristopher McKay et al.
HUMAN PATHOLOGY (2011)
Dacarbazine Promotes Stromal Remodeling and Lymphocyte Infiltration in Cutaneous Melanoma Lesions
Alessandra Nardin et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2011)
Progressive Upregulation of PD-1 in Primary and Metastatic Melanomas Associated with Blunted TCR Signaling in Infiltrating T Lymphocytes
Maxime Chapon et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2011)
A prospective phase II trial exploring the association between tumor microenvironment biomarkers and clinical activity of ipilimumab in advanced melanoma
Omid Hamid et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2011)
Immune parameters affecting the efficacy of chemotherapeutic regimens
Laurence Zitvogel et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
Anti-cancer immune response mechanisms in neoadjuvant and targeted therapy
Carsten Denkert et al.
SEMINARS IN IMMUNOPATHOLOGY (2011)
Inflammation-mediated promotion of invasion and metastasis
Graziella Solinas et al.
CANCER AND METASTASIS REVIEWS (2010)
The paradox of tumor-associated neutrophils Fueling tumor growth with cytotoxic substances
A. McGarry Houghton
CELL CYCLE (2010)
B Cells Are Required for Optimal CD4+ and CD8+ T Cell Tumor Immunity: Therapeutic B Cell Depletion Enhances B16 Melanoma Growth in Mice
David J. DiLillo et al.
JOURNAL OF IMMUNOLOGY (2010)
CD20+ B Cells: The Other Tumor-Infiltrating Lymphocytes
Brad H. Nelson
JOURNAL OF IMMUNOLOGY (2010)
FOXP3+ Cell Density in Primary Tumor Has No Prognostic Impact in Patients with Cutaneous Malignant Melanoma
Andrea Ladanyi et al.
PATHOLOGY & ONCOLOGY RESEARCH (2010)
Clinical and histopathological risk factors to predict sentinel lymph node positivity, disease-free and overall survival in clinical stages I-II AJCC skin melanoma: Outcome analysis from a single-institution prospectively collected database
M. Mandala et al.
EUROPEAN JOURNAL OF CANCER (2009)
Immune cells and angiogenesis
Domenico Ribatti et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2009)
Macrophage Markers in Serum and Tumor Have Prognostic Impact in American Joint Committee on Cancer Stage I/II Melanoma
Trine O. Jensen et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Immune profile and mitotic index of metastatic melanoma lesions enhance clinical staging in predicting patient survival
Dusan Bogunovic et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Melanoma-associated fibroblasts modulate NK cell phenotype and antitumor cytotoxicity
Mirna Balsamo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
The inflammatory micro-environment in tumor progression: The role of tumor-associated macrophages
Paola Allavena et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2008)
Favorable outcome in clinically stage II melanoma patients is associated with the presence of activated tumor infiltrating T-lymphocytes and preserved MHC class I antigen expression
Inge S. van Houdt et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
The anticancer immune response: indispensable for therapeutic success?
Laurence Zitvogel et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures
Marie-Caroline Dieu-Nosjean et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Leukocyte infiltration and tumor cell plasticity are parameters of aggressiveness in primary cutaneous melanoma
Femke Hillen et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
Failure at the effector phase: Immune barriers at the level of the melanoma tumor microenvironment
Thomas F. Gajewski
CLINICAL CANCER RESEARCH (2007)
Density of DC-LAMP+ mature dendritic cells in combination with activated T lymphocytes infiltrating primary cutaneous melanoma is a strong independent prognostic factor
Andrea Ladanyi et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
Tumor-infiltrating lymphocytes predict sentinel lymph node positivity in patients with cutaneous melanoma
Rebecca C. Taylor et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Association of microvessel density with infiltrating cells in human cutaneous malignant melanoma
Judit Kiss et al.
PATHOLOGY & ONCOLOGY RESEARCH (2007)
CD4 regulatory T cells in human cancer pathogenesis
Keith L. Knutson et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
Monocyte/macrophage infiltration in tumors: modulators of angiogenesis
Anita E. M. Dirkx et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2006)
Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: Potential targets of anti-cancer therapy
A Sica et al.
EUROPEAN JOURNAL OF CANCER (2006)
Immunohistological characterisation of tumour infiltrating lymphocytes in melanocytic skin lesions
MR Hussein et al.
JOURNAL OF CLINICAL PATHOLOGY (2006)
The predictive value of CD8, CD4, CD68, and human leukocyte antigen-D-related cells in the prognosis of cutaneous malignant melanoma with vertical growth phase
F Piras et al.
CANCER (2005)
De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent
KE de Visser et al.
CANCER CELL (2005)
Close encounters of different kinds: Dendritic cells and NK cells take centre stage
MA Degli-Esposti et al.
NATURE REVIEWS IMMUNOLOGY (2005)
T-cell activation marker expression on tumor-infiltrating lymphocytes as prognostic factor in cutaneous malignant melanoma
A Ladányi et al.
CLINICAL CANCER RESEARCH (2004)
The paradox of T cell-mediated antitumor immunity in spite of poor clinical outcome in human melanoma
A Anichini et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2004)
The plasmacytoid monocyte/interferon producing cells
F Facchetti et al.
VIRCHOWS ARCHIV (2003)
Naturally occurring B-cell responses to breast cancer
JA Coronella-Wood et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2003)
Plasmacytoid dendritic cells prime IFN-γ-secreting melanoma-specific CD8 lymphocytes and are found in primary melanoma lesions
M Salio et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2003)
New aspects of natural-killer-cell surveillance and therapy of cancer
MJ Smyth et al.
NATURE REVIEWS CANCER (2002)
分享论文
